It has been reported that glutathione (GSH), which targets CLCs, disrupts Gal‐10 CLC formation and inhibits the crystallization of human Gal‐10 by chemically modifying Cys57, thereby ameliorating asthma symptoms [64]. Here, CLC is linked to asthma.